1-hexadecyl-2-acetyl-glycero-3-phosphocholine has been researched along with Autoimmune Diabetes in 15 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 5 (33.33) | 18.7374 |
1990's | 7 (46.67) | 18.2507 |
2000's | 3 (20.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Darcan, S; Ersoy, B; Hüseyinov, A | 1 |
Bootsma, AH; Chaturvedi, N; Fuller, JH; Schalkwijk, CG; Schram, MT; Stehouwer, CD | 1 |
Akbani, H; Gilani, AH; Jabbar, A; Jafri, A; Memon, RA; Saeed, SA; Saleem, S | 1 |
Baskin, DG; Braquet, P; Goodner, CJ; Jobe, LW; Lernmark, A; Ubungen, R | 1 |
Boccellino, MR; Camussi, G; Cassader, M; Cavallo-Perin, P; De Martino, A; Furlani, D; Gruden, G; Iorio, E; Lupia, E; Montrucchio, G; Olivetti, C; Quagliuolo, L; Servillo, L | 1 |
Brachmann, P; Gängler, P; Hoffmann, T; Krause, S; Lösche, W | 1 |
Anfossi, G; Burzacca, S; Cavalot, F; De Facis, R; Lucchina, PG; Massucco, P; Mattiello, L; Mularoni, E; Trovati, M | 1 |
Burke, V; Douglas, AJ; McCulloch, RK; Mori, TA; Vandongen, R | 1 |
Baskin, DG; Beck, JC; Braquet, P; Glidden, D; Goodner, CJ; Lernmark, A; Wilson, C; Wilson, D | 1 |
Förster, W; Knospe, S; Köhler, E; Michaelis, D; Varnai, G; Wanka, H | 1 |
Bompiani, GD; Cardella, F; Davì, G; Giardina, E; Meli, F; Strano, A; Triolo, G | 1 |
Hofmann, B; Ostermann, G; Rühling, K; Schymik, C; Spangenberg, P; Till, U | 1 |
Hofmann, B; Ostermann, G; Rühling, K; Spangenberg, P | 1 |
Benveniste, J; Billerey, M; Buonocore, M; Chignard, M; Driss, F; Juhan-Vague, I; Poisson, C; Roul, C; Vague, P | 1 |
Arnold, JH; Cataland, S; Greco, NJ; O'Dorisio, TM; Panganamala, RV | 1 |
15 other study(ies) available for 1-hexadecyl-2-acetyl-glycero-3-phosphocholine and Autoimmune Diabetes
Article | Year |
---|---|
The role of platelet-activating factor in pathogenesis of type 1 diabetes.
Topics: Adolescent; Child; Child, Preschool; Diabetes Mellitus, Type 1; Humans; Platelet Activating Factor; Reference Values | 2005 |
Advanced glycation end products are associated with pulse pressure in type 1 diabetes: the EURODIAB Prospective Complications Study.
Topics: Adult; Blood Pressure; Case-Control Studies; Cross-Sectional Studies; Diabetes Mellitus, Type 1; Female; Follow-Up Studies; Glycated Hemoglobin; Humans; Linear Models; Lysine; Male; Middle Aged; Multicenter Studies as Topic; Platelet Activating Factor; Prospective Studies | 2005 |
Altered platelet activating factor metabolism in insulin dependent diabetes mellitus.
Topics: 1-Alkyl-2-acetylglycerophosphocholine Esterase; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Humans; Lipoproteins; Phospholipases A; Platelet Activating Factor | 1995 |
Protection from BB rat diabetes by the platelet-activating factor inhibitor BN50730.
Topics: Age Factors; Animals; Autoimmune Diseases; Azepines; Diabetes Mellitus, Type 1; Insulin; Islets of Langerhans; Male; Platelet Activating Factor; Rats; Rats, Inbred BB; Tetrazoles; Thienopyridines; Thyroid Gland; Thyroiditis, Autoimmune; Triazoles | 1993 |
Increased blood levels of platelet-activating factor in insulin-dependent diabetic patients with microalbuminuria.
Topics: 1-Alkyl-2-acetylglycerophosphocholine Esterase; Adult; Albuminuria; Diabetes Mellitus, Type 1; Female; Humans; Male; Phospholipases A; Platelet Activating Factor; Reference Values | 2000 |
Defective function of blood granulocytes in patients with diabetes mellitus-associated marginal periodontitis.
Topics: Adult; Cell Aggregation; Diabetes Mellitus, Type 1; Female; Free Radicals; Granulocytes; Humans; Male; Middle Aged; Oxygen; Periodontitis; Phagocytosis; Platelet Activating Factor | 1992 |
Moderate exercise increases platelet function in type I diabetic patients without severe angiopathy and in good control.
Topics: Adenosine Diphosphate; Adult; beta-Thromboglobulin; Blood Glucose; Blood Platelets; Collagen; Diabetes Mellitus, Type 1; Diabetic Angiopathies; Eating; Epinephrine; Exercise; Growth Hormone; Humans; Hydrocortisone; In Vitro Techniques; Insulin; Male; Norepinephrine; Platelet Activating Factor; Platelet Activation | 1992 |
Differential effect of aspirin on platelet aggregation in IDDM.
Topics: Adult; Aspirin; Blood Pressure; Cholesterol; Collagen; Diabetes Mellitus, Type 1; Fatty Acids, Omega-3; Humans; Linoleic Acid; Linoleic Acids; Male; Membrane Fluidity; Phospholipids; Platelet Activating Factor; Platelet Aggregation; Platelet Aggregation Inhibitors; Reference Values; Thromboxane B2 | 1992 |
Effects of ginkgolide B, a platelet-activating factor inhibitor on insulitis in the spontaneously diabetic BB rat.
Topics: Animals; Diabetes Mellitus, Type 1; Disease Models, Animal; Diterpenes; Dose-Response Relationship, Drug; Eosinophils; Female; Ginkgolides; Immunohistochemistry; Islets of Langerhans; Lactones; Male; Pancreatitis; Platelet Activating Factor; Rats; Rats, Inbred BB | 1991 |
Effects of the platelet-activating factor antagonist BN 52021 on anti-islet cytotoxicity of mononuclear cells and serum from type 1 (insulin-dependent) diabetic patients.
Topics: Adolescent; Adult; Cytotoxicity Tests, Immunologic; Cytotoxicity, Immunologic; Diabetes Mellitus, Type 1; Diterpenes; Dose-Response Relationship, Drug; Female; Ginkgolides; Humans; In Vitro Techniques; Islets of Langerhans; Lactones; Leukocytes, Mononuclear; Male; Platelet Activating Factor | 1991 |
The relationship of insulin antibodies, platelet-fixing immune complexes and platelet-associated IgG to in vitro platelet aggregation and thromboxane B2 synthesis in childhood type 1 (insulin-dependent) diabetes mellitus.
Topics: Adenosine Diphosphate; Arachidonic Acid; Arachidonic Acids; Blood Platelets; Child; Collagen; Diabetes Mellitus, Type 1; Epinephrine; Female; Humans; Immunoglobulin G; Immunoglobulins; In Vitro Techniques; Insulin Antibodies; Male; Platelet Activating Factor; Platelet Aggregation; Reference Values; Thromboxane B2 | 1989 |
Blood platelet behaviour in patients with a type I diabetes mellitus.
Topics: Actin Cytoskeleton; Actins; Adult; Blood Platelets; Diabetes Mellitus, Type 1; Female; Humans; Male; Middle Aged; Platelet Activating Factor; Platelet Aggregation | 1989 |
Enhanced degradation of platelet-activating factor in serum from diabetic patients.
Topics: Adult; Cholesterol; Cholesterol, LDL; Cholesterol, VLDL; Diabetes Mellitus, Type 1; Female; Humans; Male; Middle Aged; Platelet Activating Factor; Regression Analysis; Triglycerides | 1989 |
Possible participation of adenosine 5'-diphosphate, arachidonic acid and paf-acether in the platelet pro-aggregating effect of uncontrolled insulin-dependent diabetic erythrocytes in vitro.
Topics: Adenosine Diphosphate; Arachidonic Acid; Arachidonic Acids; Diabetes Mellitus, Type 1; Erythrocytes; Glutaral; Humans; Plasma; Platelet Activating Factor; Platelet Aggregation | 1985 |
Action of platelet-activating factor on type 1 diabetic human platelets.
Topics: Adult; Blood Glucose; Carbon Radioisotopes; Cholesterol; Diabetes Mellitus, Type 1; Epinephrine; Female; Humans; Hydroxyeicosatetraenoic Acids; Male; Middle Aged; Platelet Activating Factor; Platelet Aggregation; Radioimmunoassay; Serotonin; Thromboxane B2; Triglycerides | 1985 |